You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood acute monoblastic leukemia (M5a)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6) Trial in

Completed
Has Results
  • Childhood Acute Basophilic Leukemia
  • +14 more
  • Phoenix, Arizona
  • +96 more
Jan 20, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • trebananib
  • +3 more
  • Buffalo, New York
  • +1 more
Sep 8, 2022

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

Terminated
  • Adult Acute Basophilic Leukemia
  • +16 more
  • eltrombopag olamine
  • standard follow-up care
  • Atlanta, Georgia
  • +1 more
Jul 20, 2022

Acute Lymphoblastic Leukemia, Obesity Trial in New York (PEDALL, Standard of care)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Obesity
  • PEDALL
  • Standard of care
  • New York, New York
    Columbia University Medical Center
Jul 19, 2023

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +18 more
  • eltrombopag olamine
  • Cleveland, Ohio
    Case Comprehensive Cancer Center
Nov 29, 2021

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Trial in China (BL-M11D1)

      Not yet recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
      • Hefei, Anhui, China
      • +7 more
      Jun 27, 2023

      ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

      Not yet recruiting
      • ALL, Childhood B-Cell
      • +2 more
      • Tafasitamab
      • (no location specified)
      Nov 25, 2022

      Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,

      Recruiting
      • Childhood Non-Hodgkin Lymphoma
      • +2 more
      • Goal Management Training (GMT)
      • Brain Health Workshop (BHW)
      • Oslo, Norway
      • +2 more
      May 25, 2022

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

      Completed
      Has Results
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +16 more
      • choline magnesium trisalicylate
      • +3 more
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Aug 20, 2021

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 31, 2022

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

      Terminated
      Has Results
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +15 more
      • fludarabine phosphate
      • +4 more
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Aug 20, 2021

      Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

      Completed
      Has Results
      • Acute Undifferentiated Leukemia
      • +13 more
      • Chicago, Illinois
        Cancer and Leukemia Group B
      Apr 5, 2022

      Refractory B-cell Acute Lymphoblastic Leukemia Trial in Houston (Mosunetuzumab)

      Not yet recruiting
      • Refractory B-cell Acute Lymphoblastic Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 18, 2023

      Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

      Recruiting
      • Acute Myeloid Leukemia, Adult
      • cladribine + homoharringtonine + cytarabine
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, Zhejiang University School of Med
      Jun 13, 2023

      Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

      Not yet recruiting
      • Acute Myeloid Leukemia (AML)
      • Vienna, Austria
      • +3 more
      Jun 8, 2023

      Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

      Not yet recruiting
      • Chronic Myelomonocytic Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 10, 2023

      Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Birmingham, Alabama
      • +2 more
      Jan 3, 2023